IRIS
PIZZIGALLO, Eligio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.990
NA - Nord America 3.429
AS - Asia 1.770
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 6
SA - Sud America 5
OC - Oceania 2
Totale 9.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.407
UA - Ucraina 940
CN - Cina 927
IE - Irlanda 687
TR - Turchia 602
GB - Regno Unito 597
SE - Svezia 408
FR - Francia 403
IT - Italia 298
DE - Germania 295
FI - Finlandia 175
IN - India 147
RU - Federazione Russa 129
SG - Singapore 71
CA - Canada 19
CZ - Repubblica Ceca 18
EU - Europa 10
PL - Polonia 10
BE - Belgio 9
IL - Israele 8
VN - Vietnam 7
GR - Grecia 6
IR - Iran 5
AT - Austria 3
CH - Svizzera 3
ES - Italia 3
MX - Messico 3
SC - Seychelles 3
AR - Argentina 2
BG - Bulgaria 2
EG - Egitto 2
NL - Olanda 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
HU - Ungheria 1
KR - Corea 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 9.212
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.033
Dublin 686
Chandler 580
Southend 557
Princeton 351
Izmir 340
Nanjing 321
Wilmington 191
Cambridge 171
Beijing 121
Nanchang 119
Dearborn 114
Altamura 99
Ann Arbor 76
Boardman 62
Ashburn 58
Kunming 58
Woodbridge 57
Shenyang 54
Grevenbroich 52
Moscow 49
Singapore 44
Hebei 41
Tianjin 41
Jiaxing 35
Pune 27
Changsha 26
Norwalk 26
Hangzhou 24
Chieti 22
Houston 20
Lanzhou 20
Augusta 18
Brno 18
San Mateo 18
Toronto 18
Andover 12
Jinan 12
Los Angeles 12
Changchun 11
Rome 11
Brussels 9
Orange 9
Radomsko 9
Dong Ket 7
Falls Church 7
Leawood 7
Ningbo 7
Auburn Hills 6
Guangzhou 6
Helsinki 6
New York 6
Washington 6
Düsseldorf 5
Milan 5
Rufina 5
Sant'onofrio 5
Seattle 5
Simi Valley 5
Cedar Knolls 4
Haikou 4
Kocaeli 4
Monmouth Junction 4
Pisa 4
Shanghai 4
Zhengzhou 4
Ardabil 3
Civitavecchia 3
Edinburgh 3
Grafing 3
Madrid 3
Mexico City 3
Mileto 3
Mumbai 3
Noto 3
Pescara 3
Taizhou 3
Venafro 3
Vienna 3
Walnut 3
Bangalore 2
Bari 2
Berazategui 2
Cairo 2
Forest City 2
Fuzhou 2
Hanover 2
Hefei 2
Kirkland 2
London 2
Munich 2
Quzhou 2
San Benedetto del Tronto 2
Sofia 2
Tappahannock 2
Torino 2
Afragola 1
Amsterdam 1
Arakere 1
Avezzano 1
Totale 5.826
Salva come PNG Salva come JPEG
Nome #
Caso clinico di endoplastite da Staphylococcus capitis. 124
La sindrome di Waterhouse-Friderichsen quale complicanza fatale nel bambino febbrile: descrizione di due casi clinici. 107
Ricerche sull'autoimmunità in alcune epatopatie. 96
HPV e displasie della cervice uterina: ricerca dell'HPV-DNA con PCR e correlazioni con l'esame citologico, colposcopico e istobioptico 93
Metabolic modifications in HIV-infected women 92
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 88
I potenziali evocati uditivi troncoencefalici nella valutazione della Sindrome da Fatica Cronica. 88
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 88
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 87
Valutazione della sindrome da fatica cronica mediante A.B.R.: risultati preliminari 86
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 84
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 84
Alterations in muscles of CFS patients at morphological. biochemical and molecular level. 83
Ricerca con PCR e genotipizzazione dell'HPVDNA in donne con dispiasia della cervice uterina e nei loro partner 83
Ocular manifestations in chronic fatigue syndrome. 80
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 80
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 78
Efficacia clinica del trattamento intravescicale con BCG per neoplasie vescicali superficiali in rapporto alla risposta immunitaria indotta. 76
Autoimmunità nelle epatiti croniche in terapia con IFN-alfa 75
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 75
Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. 74
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 74
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 73
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 72
Acute urinary retention due to HSV-1: a case report 72
A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. 71
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 71
Acquired immunodeficiency without HIV infection: epidemiology and clinical autcome in Italy. 70
Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome 69
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 69
Patient-reported and Physician-estimated Adherence to HAART. 69
Psychiatric diagnosis and comorbidity and chronic fatigue syndrome 68
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 68
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 68
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 67
Circadian variations of prolactine (PRL), thyreotropic hormone (TSH), adrenocorticotropic hormone (ACTH) and cortisol (CS) in the chronic fatigue syndrome (CFS). 66
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. 66
Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. 65
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 65
High dose of erythropoietin in management of interferon/ribavirin induced anemia 65
Inguinal lymphadenopathy due to Bartonella henselae 65
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. 65
Valutazione comparativa delle tecniche di immunodiffusione su agar e counter-elettroforesi nella ricerca dell'antigene Australia. 64
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 64
MR imaging in the clinical diagnosis of chronic fatigue syndrome (CFS). 64
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 63
Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. 63
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report 63
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 63
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. 62
Attualità sulle infezioni batteriche del SNC. 61
Hepatitis C virus infection and myositis: a virus localization study. 61
Insights the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients 61
The association of chronic hepatitis B and myopathy 60
Interruption of highly active antiretroviral therpy in HIV clinical practice. 60
Proteinuria in an African HIV-infected patient: effects of telmisartan. 60
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 59
Granulomatous cheilitis in an HIV positive patient on HAART Therapy. 59
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 59
b-endorphin concentrations are decreased in peripheral blood mononuclear cells of chronic fatigue syndrome patients: comparison with depression. 59
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 59
An unusual complication of brucellosis: hepatic abscess. 58
Neurite acistica bilaterale HIV-correlata: descrizione di un caso ad evoluzione favorevole in seguito a terapia antiretrovirale. 57
Ricerca degli anticorpi fissanti il complemento contro il virus dell'herpes simplex (ed altri virus neurotropi) in pazienti con sclerosi multipla. 57
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. 56
Ulteriori osservazioni sul sistema HBeAg-HBeAb in corso di epatite ed in portatori di HBsAg. 56
Ricerca dell'anticorpo contro il virus A (=HAAb) per l'epidemiologia e la diagnosi dell'epatite A. 56
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. 55
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. 55
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. 55
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 55
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. 54
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 54
Determinazione dell'antigene Australia con il metodo radioimmunologico in corso di epatite virale. 54
Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center 53
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. 53
Submaximal aerobic exercise with mechanical vibrations improves the functional status of patients with Chronic Fatigue Sindrome. 53
Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression 53
Le associazioni di antibiotici: aspetti clinici. 53
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values? 53
Study of immune alterations in patients with Chronic Fatigue Syndrome to reach a better nosografic and pathogenetic characterization of subgroups with different etiologies. 52
L'immunità cellulare nelle epatopatie: stimolazione in vitro dei linfociti con antigeni epatici. 52
Occurence of bacteriemia in hematological patients. 51
Chronic fatigue syndrome following a toxic exposure. 51
Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in cohort of antiretroviral-naive HIV-infected individuals. 51
Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis. 51
Comparative analysis of two systems for HCV genotyping. 50
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 50
Nuovi aspetti della terapia antibiotica associata (rassegna critica e contributo personale). 50
Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. 49
Genetic polymorphisms differently influencing the emergence of atrophy and far accumulation in HIV-related lipodystrophy. 49
Prognostic factors of early fatal outcome and long-term survival in patients with pneumocistis carinii pneumonia and acquired immunodeficiency syndrome. 48
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 48
Research on a new hepatitis B antigen-antibody system: e- anti-e. 48
The cytokine phenotypes 1 and 2 in progression of HIV-1 infection and changes induced by antiretroviral therapy 48
Long-term lymphoblastoid interferon-alfa therapy for non-cirrhotic chronic hepatitia C: an Italian multicentre study on dose and duration of IFNalfa treatment. 47
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART. 47
Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I. CO.N.A.) Study. 47
Epatite A ed epatite B. Elementi clinici, epidemiologici ed immunologici differenziali. 47
null 47
Totale 6.446
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.985 715 167 8 61 152 107 211 196 28 105 223 12
2020/2021991 185 9 185 4 88 197 8 6 83 179 12 35
2021/2022597 7 3 5 103 47 12 11 68 52 13 85 191
2022/20231.921 206 271 112 187 178 404 136 112 226 18 27 44
2023/2024708 58 27 34 18 33 205 238 19 0 6 5 65
2024/2025154 154 0 0 0 0 0 0 0 0 0 0 0
Totale 9.438